Browsing by Author Hala M. H. Abaza


Or, select a letter below to browse by last name
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 15 to 34 of 37 < previous   next >
Issue DateTitleAuthor(s)
May-1993Hemostasis Time, Platelet Aggregation, Platelet Factor 4, von Willebrand Factor and Fibronectin in Childhood Chronic ITP.Mottier G A H ; Hala M. H. Abaza 
Sep-1992Immunophenotype-Karyotype Associations in Egyptian Acute Lymphoblastic Leukemia [ALL].Osaima E Selim ; Ahmed S Khalifa ; Mohamed A Awadalah ; Salwa M Youssef ; Mohamed El-Sawi ; Hala M. H. Abaza ; Hoda El-Gindi 
Jun-1990Immunophenotypic Classification of Acute Non-Lymphoblastic Leukemias [ANLLs].Osaima E Selim ; Ahmed S Khalifa ; Henry Rochant ; Salwa M Youssef ; Hala M. H. Abaza 
1998Iron Status in Neonates with ABO immune Hemolytic Disease.Mottier G A H ; Hala M. H. Abaza 
Jun-1995Kappa/Lambda Analysis in the Early Detection of Lymphoproliferative Disorders.Salwa M Youssef ; Hala M. H. Abaza ; Hoda M El-Gendi ; Nermin I Ezzat 
Mar-1999Late Sequelae of Chemo/radiotherapy in Egyptian Pediatric Hodgkin's Disease.Hala Abaza ; Mohamed S. Zaghloul ; Samya Y. Akle ; Zekri K. Zekri ; Aya M. H. Abaza ; Safinaz EI-Habashy ; Amin Abo-GabaI 
Sep-1998Maternal and fetal outcome of Homozygous Sickle Cell Disease [HbSS] Pregnancy in the Eastern-Province of Saudi Arabia.Omaima A-M. Tawfiq ; Hala M. H. Abaza ; Naglaa A. Al-Shabrauy ; Ahmed M. T. Abdulla ; Salah A. K. Abdulwahed 
Jan-1994Monitoring Heparin and Low Molecular Weight Heparin (LMWH) Therapy with Clotting versus Chromogenic Substrate Assays.Nevine A Kassim ; Hala M. H. Abaza 
Feb-1993Monitoring of Prophylactic Doses of Unfractionated and LMW Heparin by APTT, TT and Anti-Xa Activity.Sawsan A Fayad ; Nevine A Kassim ; El-Deeb M M ; Hala M. H. Abaza ; Manal F G Ahmed 
Jun-1993Neuroblastoma in the Pediatric Age Group.Ahmed S. Kalifa ; Inas A. El-Attar ; Safinaz A. El-Habashy ; Galila M. Mokhtar ; Hala M. H. Abaza ; Aya M. Abaza 
1-Apr-2018Neuropilin-1/CD304 expression by flow cytometry in Pediatric precursor B-acute lymphoblastic leukemia: A Minimal Residual Disease and Potential Prognostic Marker.Hala Abaza ; Abdel Fattah Mona F ; A nnaka Laila M ; Ebeid Fatma S ; Eissa Deena SN ; Alfeky Mervat AA 
Jan-1995Neutrophil Dysfunction in Chronic Myeloid Leukemia [CML].Mohamed S Sabour ; Faiza A W Hammmouda ; Inas A Asfour ; Salwa M Aboul-Hana ; Hala M. H. Abaza ; Eman A Hafez 
Jun-1993A New Rapid Colorimetric Assay for Measuring Mixed Lymphocyte Reactions Using A Tetrazolium Salt Substrate.Osaima E. Selim ; Hala M. H. Abaza ; Salwa M. Youssef ; Salwa Abou El-Hana ; Afaf Abd El-Aziz 
May-1993Plasma Fibronectin, Fibrinogen and Platelets as Indicators for Reversal of Endothelial Cell Damage after Delivery in Severe Pregnancy-Induced Hypertension [PIH].Mohamed A El-Nazer ; Hala M. H. Abaza 
1-Jan-2016Platelet-dependent von Willebrand factor activity in acute myeloid leukemia patients: role in hemostatic alterationsAbaza H.M,H ; SF Samaan ; BAT Farweez 
Jul-1991Prevalence of Antibodies to Hepatitis C Virus [HCV] in Egyptian Haemodialysis Patients.Osaima E Selim ; Hala M. H. Abaza ; El-Zayadi A ; Mona M Rafik ; Heba A Sedky 
May-1993Prevalence of Hepatitis C Virus Antibodies [HCV-Absl among Egyptian Blood Donors.Osaima E Selim, , , and ; El-Zayadi A ; Salwa Aboul-Hana ; Hala M. H. Abaza ; Evette Nasr. 
Oct-1993Protein C and Protein S Levels in Egyptian Women during the Different Trimesters of Normal PregnancySalwa M Abou El-Hana ; Hala M. H. Abaza ; Salwa S Khodeir ; Soheir M Afia 
Jan-2010Quantification of BCR/ABL fusion transcripts in chronic myeloid leukemia: follow up of therapeutic regimens and detection of minimal residual disease by real time polymerase chain reaction.Hala Abaza ; Mostafa G M H ; Negm Z M G ; Khattab D A ; Foad D A ; El-Arab S E 
1-Feb-2016Stanniocalcin1 gene expression in patients with acute leukemia: impact on response to therapy and disease outcomeHala Abaza ; H. M. Mahmoud ; H. M. A. El Maraghy ; M. I. Elmougy 
Showing results 15 to 34 of 37 < previous   next >